Skip to main content
Equibles

BARCLAYS PLC

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,621,237
+$627,646 QoQ
Shares Held
143,945
+2.6% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 183 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. CGEM ranks #59 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in CGEM

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,621,237 143,945
2026-03-31 $1,993,591 140,295
2025-12-31 $2,790,928 269,655
2025-09-30 $1,489,081 251,110
2025-06-30 $2,021,555 268,467
2025-03-31 $1,826,966 241,343
2024-12-31 $2,986,913 245,231
2024-09-30 $4,161,798 248,614
2024-06-30 $3,441,156 197,314
2024-03-31 $684,871 40,192
2023-12-31 $868,431 85,224
2023-09-30 $483,205 53,393
2023-06-30 $233,954 21,743
2023-03-31 $289,641 28,313
2022-12-31 $226,782 21,496
2022-09-30 $115,303 8,994
2022-06-30 $93,111 7,263
2022-03-31 $76,724 7,328